Carsten Reinhard
Managing Director and Chief Medical Officer
Management
Immatics Biotechnologies
Germany
Biography
Dr Carsten Reinhardt joined Immatics Biotechnologies GmbH in October 2009 from Micromet, Inc. (Bethesda, MD), where he was Chief Medical Officer and a member of the management board. Previously, as International Medical Leader at Hoffmann-La Roche (Basel, Switzerland), Dr Reinhardt had global responsibility for the development of Herceptin®. Prior to his tenure at Roche, Dr Reinhardt was Head of Clinical Development at Fresenius Biotech (Munich, Germany).
Research Interest
Management
